Powered by

Powered by Portfolio Grader

Ligand Pharm (LGND)

124.63 5.60 (4.70%) 20:31 EDT
LGND Stock Quote Delayed 15 Minutes

  • LGND Stock Chart

  • Historical LGND Prices

  
Dividend & Yield:       N/A (N/A)
P/E:       58.24
Market Cap:       2.65B
EPS:       2.14
Volume:       840,100
Day's Range:       118.90 - 125.90
52wk Range:       98.56 - 278.62
Quotes delayed at least 20 mins.
Historical Data for LGND
Month:  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Year:  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Range:  1 Month 3 Month 1 Year
Date Open High Low Volume Close Change %
03/18/19 119.99 125.90 118.90 840,091 124.63 5.60   4.70%
03/15/19 118.06 119.29 115.67 1,474,000 119.03 0.83   0.70%
03/14/19 116.31 119.59 116.31 549,998 118.20 1.89   1.62%
03/13/19 114.29 117.51 112.51 581,414 116.31 2.96   2.61%
03/12/19 112.13 113.76 109.63 451,722 113.35 2.37   2.14%
03/11/19 106.42 111.00 105.72 568,891 110.98 5.05   4.77%
03/08/19 105.37 107.15 104.48 1,036,100 105.93 -0.47   -0.44%
03/07/19 106.28 107.38 104.63 907,099 106.40 -0.10   -0.09%
03/06/19 117.65 118.25 104.28 3,600,323 106.50 -14.11   -11.70%
03/05/19 123.00 123.00 120.52 267,317 120.61 -2.08   -1.70%
03/04/19 127.23 127.38 120.18 359,767 122.69 -3.65   -2.89%
03/01/19 125.24 127.06 124.19 337,100 126.34 2.26   1.82%
02/28/19 126.69 129.12 123.87 536,373 124.08 -2.66   -2.10%
02/27/19 123.37 128.36 122.95 448,531 126.74 2.91   2.35%
02/26/19 122.67 125.70 121.64 612,708 123.83 0.32   0.26%
02/25/19 120.98 124.43 120.02 498,558 123.51 4.13   3.46%
02/22/19 117.68 119.61 116.00 334,300 119.38 2.20   1.88%
02/21/19 118.82 119.95 116.10 327,273 117.18 -1.73   -1.45%
02/20/19 118.51 120.53 117.27 399,157 118.91 0.16   0.13%
02/19/19 120.87 121.29 117.88 449,454 118.75 -2.11   -1.75%
02/15/19 121.53 122.84 120.12 463,300 120.86 -0.02   -0.02%
02/14/19 120.26 122.00 119.21 343,689 120.88 0.44   0.37%
02/13/19 120.63 121.43 118.72 307,336 120.44 0.68   0.57%
02/12/19 118.49 119.87 116.92 480,213 119.76 1.79   1.52%
02/11/19 115.10 119.20 111.81 693,163 117.97 3.49   3.05%
02/08/19 120.00 120.85 113.22 1,378,600 114.48 -2.04   -1.75%
02/07/19 117.52 120.54 114.00 743,161 116.52 -1.12   -0.95%
02/06/19 116.71 119.76 116.71 327,925 117.64 0.71   0.61%
02/05/19 120.75 122.48 116.84 437,824 116.93 -4.26   -3.52%
02/04/19 120.33 121.26 118.21 327,223 121.19 0.98   0.82%
02/01/19 118.90 120.89 116.32 612,800 120.21 2.11   1.79%
01/31/19 117.54 119.43 117.19 390,315 118.10 0.48   0.41%
01/30/19 116.12 118.16 115.25 354,805 117.62 1.66   1.43%
01/29/19 114.84 116.51 114.17 365,044 115.96 1.85   1.62%
01/28/19 114.15 114.39 111.58 465,334 114.11 -0.73   -0.64%
01/25/19 113.10 115.08 112.31 536,900 114.84 1.79   1.58%
01/24/19 112.00 114.75 111.50 411,382 113.05 1.27   1.14%
01/23/19 113.70 116.32 111.01 581,371 111.78 -1.13   -1.00%
01/22/19 116.72 118.35 112.31 746,170 112.91 -4.99   -4.23%
01/18/19 111.46 120.65 109.91 1,292,800 117.90 7.18   6.48%
01/17/19 110.31 115.45 106.16 2,181,988 110.72 0.67   0.61%
01/16/19 130.50 131.00 98.56 8,569,517 110.05 -21.72   -16.48%
01/15/19 128.11 132.74 127.20 574,053 131.77 3.40   2.65%
01/14/19 133.70 133.70 126.76 994,579 128.37 -6.32   -4.69%
01/11/19 135.65 137.38 132.85 411,300 134.69 -1.28   -0.94%
01/10/19 140.91 140.91 129.46 904,840 135.97 -6.04   -4.25%
01/09/19 140.93 144.95 140.00 510,302 142.01 1.66   1.18%
01/08/19 143.72 144.71 139.53 410,102 140.35 -2.12   -1.49%
01/07/19 138.61 142.94 137.54 529,568 142.47 4.72   3.43%
01/04/19 134.94 140.74 134.94 407,100 137.75 5.11   3.85%
01/03/19 137.43 138.20 132.49 421,667 132.64 -4.36   -3.18%
Download Data To Spreadsheet
Ligand Pharm (LGND) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Ligand Pharm Stock Analysis

Rating: Sell

Total Grade: D

Analysis Breakdown

LGND Stock Grade: D
Fundamental Grade: B
Quantitative Grade: D
LGND Earnings
Earnings Growth: C
Earnings Momentum: F
Earnings Surprises: A
Analyst Earnings Revisions: A
LGND Financial Information
Sales Growth: B
Operating Margin Growth: C
Cash Flow: C
Return on Equity: A

Ligand Pharm Stock: Weekly View

This Week: D
Last Week: D
Two Weeks Ago: D
Get Full Report